|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 272.00 DKK | -4.17% |
|
-4.53% | -16.37% |
| Jun. 08 | Use of GLP-1 drugs early in pregnancy should not cause alarm, analysis suggests | RE |
| Jun. 08 | Health Care Ticks Down Amid Deal Activity - Health Care Roundup | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 194B | |||||
| 1,009B | |||||
| 560B | |||||
| 401B | |||||
| 328B | |||||
| 298B |
- Stock Market
- Stocks
- NOVO B Stock
- Charts Novo Nordisk A/S
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
